Market Place
Sourcing Support
Zevra Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results
28 Mar 2024 //
GLOBENEWSWIRE
Journal Frontiers in Psychiatry Publishes Analysis of With ADHD
26 Jun 2023 //
PR NEWSWIRE
Corium`s Medication AZSTARYS Had No Significant Impact on Children`s Weight
22 May 2023 //
PR NEWSWIRE
Corium`s Novel ADHD Medication AZSTARYS Shown Safe and Effective in Study
22 Feb 2023 //
PR NEWSWIRE
KemPharm Receives FDA Orphan Designation for Serdexmethylphenidate for (IH)
18 Nov 2022 //
GLOBENEWSWIRE
Corium to Present Positive Data on AZSTARYS and ADLARITY at Psych Congress 2022
13 Sep 2022 //
PRNEWSWIRE
Serdexmethylphenidate Has Low Relative Potential for Abuse
01 Jun 2022 //
BIOSPACE
Corium To Present at Academy of Managed Care Pharmacy
28 Mar 2022 //
PRNEWSWIRE
KemPharm Announces Full Data Set from Higher-Dose SDX Phase 1 Trial
21 Mar 2022 //
GLOBENEWSWIRE
KemPharm to Feature Research Involving Serdexmethylphenidate in Presentations
11 Jan 2022 //
GLOBENEWSWIRE
Ark Bio Enters Into Excl License Agreement for Azstarys
29 Dec 2021 //
ASIAONE
Significant ADHD Symptom Improvement with 30-Minute Onset and 13-Hour Duration
29 Oct 2021 //
PRNEWSWIRE
KemPharm Announces Research Involving AZSTARYS® and Serdexmethylphenidate
20 Oct 2021 //
GLOBENEWSWIRE
Once-Daily AZSTARYS® , First &Only Product Containing Dexmethylphenidate Prodrug
14 Oct 2021 //
PRNEWSWIRE
Corium Secures $235 Million in Debt Financing
27 Sep 2021 //
PRNEWSWIRE
KemPharm Announces FDA Approval of AZSTARYS™
03 Mar 2021 //
GLOBENEWSWIRE
U.S. Food and Drug Administration Approves Novel Once-Daily Capsule AZSTARYS™
03 Mar 2021 //
PRNEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.